1,008
Views
19
CrossRef citations to date
0
Altmetric
Drug Profile

Secukinumab (AIN457) for the treatment of psoriasis

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ulrich Amon, Laura Baier, Raul Yaguboglu, Madeleine Ennis, Michael F. Holick & Julian Amon. (2018) Serum 25-hydroxyvitamin D levels in patients with skin diseases including psoriasis, infections, and atopic dermatitis. Dermato-Endocrinology 10:1.
Read now
Caleb Jeon, Sahil Sekhon, Di Yan, Ladan Afifi, Mio Nakamura & Tina Bhutani. (2017) Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis. Human Vaccines & Immunotherapeutics 13:10, pages 2247-2259.
Read now

Articles from other publishers (17)

Hyun-Ji Lee & Miri Kim. (2023) Challenges and Future Trends in the Treatment of Psoriasis. International Journal of Molecular Sciences 24:17, pages 13313.
Crossref
Lan‐Tu‐Ya Wu, Zhu‐Hui Qiao, Jia‐Bin Tian, Jia‐Lin Lin, Su‐Chun Hou & Xiao‐Ming Liu. (2023) The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity. Skin Research and Technology 29:7.
Crossref
酉丰 何. (2023) Research Progress of Interleukin-17 in Related Skin Diseases. Advances in Clinical Medicine 13:04, pages 5229-5235.
Crossref
Mihaela Surcel, Adriana Munteanu, Gheorghita Isvoranu, Alef Ibram, Constantin Caruntu, Carolina Constantin & Monica Neagu. (2021) Unconventional Therapy with IgY in a Psoriatic Mouse Model Targeting Gut Microbiome. Journal of Personalized Medicine 11:9, pages 841.
Crossref
Arianna Brevi, Laura Lucia Cogrossi, Giulia Grazia, Desirée Masciovecchio, Daniela Impellizzieri, Lucrezia Lacanfora, Matteo Grioni & Matteo Bellone. (2020) Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer. Frontiers in Immunology 11.
Crossref
Michio Tokuyama & Tomotaka Mabuchi. (2020) New Treatment Addressing the Pathogenesis of Psoriasis. International Journal of Molecular Sciences 21:20, pages 7488.
Crossref
Haoyu ZouIsrath Jahan TuhinMasuma Akter MontyShenggen LuoJiaqi ShaoZhiqiang YanLei Yu. (2020) Gene Therapy for Hepatocellular Carcinoma Using Adenoviral Vectors Delivering a Gene Encoding IL-17A-Neutralizing Antibody Fragments. Human Gene Therapy 31:19-20, pages 1074-1085.
Crossref
Clinton B. Mathias. 2020. Pharmacology of Immunotherapeutic Drugs. Pharmacology of Immunotherapeutic Drugs 141 174 .
Kunal Malik, Helen He, Thy Nhat Huynh, Gary Tran, Kelly Mueller, Kristina Doytcheva, Yael Renert-Yuval, Tali Czarnowicki, Shai Magidi, Margaret Chou, Yeriel D. Estrada, Huei-Chi Wen, Xiangyu Peng, Hui Xu, Xiuzhong Zheng, James G. Krueger, Amy S. Paller & Emma Guttman-Yassky. (2019) Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature. Journal of Allergy and Clinical Immunology 143:2, pages 604-618.
Crossref
Carolina M. Pfaff, Yvonne Marquardt, Katharina Fietkau, Jens M. Baron & Bernhard Lüscher. (2017) The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function. Scientific Reports 7:1.
Crossref
Júlia Vide & Sofia Magina. (2017) Moderate to severe psoriasis treatment challenges through the era of biological drugs. Anais Brasileiros de Dermatologia 92:5, pages 668-674.
Crossref
Wendy Cantrell. (2017) Psoriasis & psoriatic therapies. The Nurse Practitioner 42:7, pages 35-39.
Crossref
T. V. Korotaeva, E. G. Zotkin, O. B. Nesmeyanova, N. N. Vezikova, O. B. Ershova, N. V. Izmozzherova, M. S. Petrova, A. A. Kastanyan, S. P. Yakupova, A. S. Agafina, M. L. Stanislav, E. A. Novoderezhkina, E. L. Nasonov & P. J. Mease. (2017) Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE 2. Rheumatology Science and Practice 55:2, pages 151-158.
Crossref
Amy S. Paller, Yael Renert-Yuval, Maria Suprun, Hitokazu Esaki, Margeaux Oliva, Thy Nhat Huynh, Benjamin Ungar, Norma Kunjravia, Rivka Friedland, Xiangyu Peng, Xiuzhong Zheng, Yeriel D. Estrada, James G. Krueger, Keith A. Choate, Mayte Suárez-Fariñas & Emma Guttman-Yassky. (2017) An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis. Journal of Allergy and Clinical Immunology 139:1, pages 152-165.
Crossref
Yaxiong Deng, Christopher Chang & Qianjin Lu. (2016) The Inflammatory Response in Psoriasis: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 50:3, pages 377-389.
Crossref
Özge UluçkanMaria JimenezSusanne KarbachAnke JeschkeOsvaldo GrañaJohannes KellerBjörn BusseAndrew L. CroxfordStephanie FinzelMarije KoendersWim van den BergThorsten SchinkeMichael AmlingAri WaismanGeorg SchettErwin F. Wagner. (2016) Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts. Science Translational Medicine 8:330.
Crossref
Takatoshi Yogo, Hiroyuki Nagamiya, Masaki Seto, Satoshi Sasaki, Huang Shih-Chung, Yusuke Ohba, Norihito Tokunaga, Gil Nam Lee, Chul Yun Rhim, Cheol Hwan Yoon, Suk Young Cho, Robert Skene, Syunsuke Yamamoto, Yousuke Satou, Masako Kuno, Takahiro Miyazaki, Hideyuki Nakagawa, Atsutoshi Okabe, Shogo Marui, Kazuyoshi Aso & Masato Yoshida. (2016) Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4 H -pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors . Journal of Medicinal Chemistry 59:2, pages 733-749.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.